However, EGFR mutations have also been found in 1/12 brain metastases from breast and 3/9 metastases from other primary cancers, suggesting that activation of the EGFR pathway may play a role in the metastatic development of breast cancer [20]. The gene discussed is EGFR; the disease is breast carcinoma.